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Abstract Pancreatic duodenal homeobox-containing transcrip-
tion factor 1 (PDX-1) plays a crucial role in pancreas
development and L-cell gene regulation. Absence of PDX-1
leads to pancreas agenesis and its malfunction causes MODY4
diabetes mellitus. PDX-1 has been suggested to be involved in the
glucose-dependent regulation of insulin gene transcription.
Whereas DNA-binding and transactivation domains of PDX-1
are in the process of being characterized, protein sequences
responsible for its nuclear translocation remain unknown. By
combining site-directed mutagenesis of putative phosphorylation
sites and nuclear localization signal (NLS) motifs with on-line
monitoring of GFP-tagged PDX-1 translocation, we demon-
strate that the NLS motif RRMKWKK is necessary and in
conjunction with the integrity of the ‘helix 3’ domain of the PDX-
1 homeodomain is sufficient for the nuclear import of PDX-1.
Furthermore, we show that there is no glucose-dependent
cytoplasmic-nuclear cycling of PDX-1.
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1. Introduction
Nuclear translocation of transcription factors is a crucial
requirement for their action and stimulus-dependent nuclear
translocation can serve as a mechanism to regulate gene ex-
pression at the level of transcription initiation. The pancreatic
duodenal homeobox (PDX)-containing transcription factor
PDX-1 (identical or homologue to IPF-1 [1], IDX-1 [2],
STF-1 [3], GSF [4], GSTF [5] and IUF-1 [6]) has been shown
to have a dual function in gene regulation. During ontogen-
esis, PDX-1 is crucial for pancreas development and the ma-
turation of premature L-cells into mature insulin-producing L-
cells in the islet of Langerhans [7,8]. Absence of PDX-1 leads
to agenesis of the pancreas [7,8] and its malfunction has been
shown to cause diabetes in animals [9,10] and leads to the
development of the MODY-type of diabetes in man, i.e.
MODY4 [11]. In the adult, PDX-1 has been discussed to be
involved in the transcriptional control of pancreatic islet L-
cell-expressed genes, such as insulin, glucokinase, amylin, the
islet N-cell-expressed somatostatin gene (for review, see [12])
and has recently been reported to contribute to pancreatic
exocrine elastase gene expression [13]. In insulin gene tran-
scriptional control, PDX-1 has been shown to bind to
A-box motives (for nomenclature, see [14]) and has been sug-
gested to be involved in the glucose-stimulated up-regulation
of insulin gene transcription. We have recently shown that
glucose acutely activates insulin gene transcription [15] and
that mutation of the PDX-1-binding A1-box in the rat insulin
I promoter abolishes short-term glucose-stimulated insulin
gene transcription [16]. As a possible mechanism of short-
term activation of insulin gene transcription by PDX-1, the
glucose-dependent nuclear translocation of the transcription
factor has been discussed [17,18]. Although the molecular
mechanisms of PDX-1 action are in the process of being ad-
dressed, i.e. its general domains such as the N-terminally lo-
cated transactivation domain, the DNA-binding homeobox
and the C-terminal domain have been described (for review,
see [12]), the molecular basis of its nuclear translocation re-
mains poorly understood.
In the present paper, we aimed to identify amino acid se-
quences that are responsible for the nuclear translocation of
mouse PDX-1. Site-directed mutagenesis of putative phos-
phorylation sites and of positively charged amino acid resi-
dues in putative nuclear localization signal (NLS) motifs of
GFP-tagged PDX-1 revealed that not a speci¢c phosphoryla-
tion site but the presence of the NLS motif RRMKWKK is
necessary and in conjunction with the integrity of the ‘helix 3’
domain of the PDX-1 homeodomain, su⁄cient for nuclear
translocation of PDX-1 in insulin-producing MIN6 cells.
2. Materials and methods
2.1. Plasmids
The cDNA of mouse PDX-1 (i.e. mouse IPF-1) was kindly pro-
vided by Dr H. Edlund (Dept. Microbiology, University of Umeafi,
Sweden). To generate pB.RSV.PDX-1VGFP, the PstI site in the
PDX-1 cDNA was used for in-frame fusion of GFP. To obtain
GFPVPDX-1, we introduced a HpaI site into the PDX-1 cDNA
by substituting nucleotides encoding Met1, i.e. ATG for TTG. Fol-
lowing digestion with HpaI/BamHI, the PDX-1-SV40-polyA cassette
was introduced into SmaI/BamHI-opened pB.CMV.GFP0, thus gen-
erating pB.CMV.GFPVPDX-1. To obtain pB.CMV.GFPVPDX-
1185ÿ209 and pB.CMV.GFPVPDX-1193ÿ209, an EcoRV site was intro-
duced into the PDX-1 cDNA exchanging codons for Ala19 and Phe20
for GATATC. Following further introduction of a HpaI site by
changing codon TTG (Leu184) for GTT or of an EcoRV site by
changing codon AAA (Lys192) for GAT, sequences encoding amino
acids 20^183 and 20^192, respectively, were deleted by restriction
enzyme digestion and re-ligation. The stop codon after amino acid
Lys209 was introduced by changing codon CGT (Arg210) for TGA.
Plasmid pB.PDX-1194ÿ208VGFP was generated by changing Ile193
into Met, thus providing a translation start site, and fusing PDX-1
cDNA encoding amino acids MVWFQNRRMKWKKEEDK208 in-
frame with the GFP cDNA. The PDX-1194ÿ208VGFP expression cas-
sette was subcloned into a pRcCMVi backbone plasmid, i.e. pRc/
CMV (Invitrogen) shortened by BamHI digestion/re-ligation. As the
control plasmid served pRcCMVi.GFP, i.e. pRcCMVi containing the
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‘humanized’ enhanced version of GFP (L64F, S65T). All mutations
were performed by employing the QuikChange Mutagenesis kit (Stra-
tagene) and respective oligonucleotides purchased from Genset
(France). All constructions were veri¢ed by DNA sequence analysis.
Plasmid pK7-GR-GFP [19] for expression of GFP-tagged glucocorti-
coid receptor was kindly provided by Dr I. Macara (Dept. Pathology,
University of Vermont, Burlington, VT, USA).
2.2. Cell culturing and gene expression
MIN6 cells [20] were obtained from Dr J. Miyazaki (Dept. Nutri-
tion and Physiol. Chemistry, Osaka University School of Medicine,
Osaka, Japan) and were adopted to culture at 11.1 and 5.5 mM
glucose in Dulbecco’s modi¢ed Eagle medium (DMEM). Cells were
grown on 24 mm glass coverslips and transfected by the lipofectamine
technique as previously described [21] with the following modi¢cation.
Transfection was carried out in a 35 mm culture dish using 2.5 Wg
DNA and 7.5 Wl lipofectamine. Following transfection, cells were
cultured for a further 24 h in DMEM containing the glucose concen-
trations indicated in the text, 10% fetal calf serum, 100 Wg/ml strep-
tomycin and 100 U/ml penicillin, at 5% CO2 and 37‡C.
2.3. Laser scanning confocal microscopy
Laser scanning confocal microscopy was performed as described
previously [15], using a Leica CLSM (Leica Lasertechnik, Heidelberg,
Germany). Cells were prepared and treated as described above. Cov-
erslips were placed in a perifusion chamber, which was mounted on a
Leica Fluovert FU inverted microscope (Leica Lasertechnik, Heidel-
berg, Germany). The temperature was kept at 37‡C. For the confocal
microscope, the following settings were used: 100U/1.30 oil Leitz
Fluotar objective lens, excitation wavelength 488 nm (krypton/argon
laser), excitation ¢lter HQ470/40, dichroic mirror Q495LP and emis-
sion ¢lter HQ525/50. Presentation images were generated using Adobe
Photoshop version 4.0.
3. Results and discussion
Nuclear translocation of proteins can be accomplished by a
diversity of mechanisms (for review, see [22]). In general, the
cargo is recognized in the cytoplasm by a receptor via a nu-
clear location signal, NLS, presented by the cargo. Following
binding to the receptor, often called importin or karyopherin,
the cargo-receptor complex is recognized by Ran, translocated
through the nuclear pore complex and the cargo is released
inside the nucleus. The translocation of the cargo-receptor
complex requires Ran’s GTPase cycle. In case that the cargo
itself does not possess a NLS, it can be imported by a piggy-
back mechanism after binding to a NLS-containing piggyback
partner. Data from a recent report by Macfarlane et al. [17]
suggest that when PDX-1 is translocated to the nucleus, it
undergoes a modi¢cation that results in a 15 kDa shift in
Western blot analysis and that translocated PDX-1 is phos-
phorylated. Both phosphorylation/dephosphorylation and the
presence of a NLS, very often formed by a stretch of the
positively charged amino acids arginine and lysine, have
been shown to be involved in nuclear translocation of tran-
scription factors (see for review [23]).
In order to identify amino acid residues in PDX-1 that are
responsible for its nuclear translocation, we performed site-
directed mutagenesis of putative phosphorylation sites as well
as of stretches of positively charged amino acids in the GFP-
tagged PDX-1 (see Fig. 1) and studied the nuclear transloca-
tion of the respective mutants by laser scanning confocal mi-
croscopy. In addition, this approach allows us to monitor on-
line stimulus-induced nuclear translocation of transcription
factors.
The predominant intranuclear localization of GFP-tagged
PDX-1 (compare with cytoplasmic and nuclear localization of
GFP-tagged glucocorticoid receptors, Fig. 2A), carrying the
tag at either the N-(GFPVPDX-1) or the C-terminus (PDX-
1VGFP), shows that the tag did not disturb the nuclear
translocation of the chimera and that the chosen conditions
did not lead to a saturation of the import mechanism (Fig.
2B,C).
3.1. The involvement of putative phosphorylation sites in
nuclear translocation of PDX-1
Phosphorylation of transcription factors is one of the mech-
anisms to unmask a hidden NLS and thereby allow for bind-
ing of the cargo to its receptor. Computer analysis of the
mouse PDX-1 amino acid sequence by employing the PRO-
SITE software package revealed the presence of nine putative
phosphorylation sites. Each of the respective putative phos-
phorylation sites was changed by site-directed mutagenesis
into an alanine (Ser61, Ser66, Ser125, Thr152, Thr187, Ser211,
Thr231, Ser232) or arginine residue (Ser211) in C-terminally
GFP-tagged mouse PDX-1. Transient expression and subcel-
lular localization of the respective PDX-1VGFP chimeras in
MIN6 cells was analyzed by laser scanning confocal micros-
copy. As shown in Fig. 2D^L, none of the mutated putative
phosphorylation sites alone abolished the translocation of
PDX-1VGFP to the nucleus.
3.2. The involvement of Arg/Lys stretches in nuclear
translocation of PDX-1
Classical NLSs have been suggested to be formed by a
hexapeptide (1) that consists of four or more positively
charged amino acids (Arg and/or Lys), (2) that contains no
bulky amino acids, such as Phe, Trp, Tyr, (3) that contains no
Asp and Glu residues, (4) that is £anked by acidic residues
proline and glycine that break K-helices and (5) that contains
no hydrophobic residues in the core NLS £anking region [23].
Analysis of the mouse PDX-1 amino acid sequence did not
Fig. 1. Schematic representation of GFP-tagged PDX-1 fusion pro-
teins. The GFP moiety is shown as a black bar, the PDX-1 part is
shown as a white bar. Numbers above the PDX-1 part indicate the
respective PDX-1 amino acids according to mouse PDX-1. The gray
area in PDX-1VGFP delineates the homeodomain of PDX-1. Ar-
rows show the localization of mutated putative phosphorylation
sites, ¢lled circles indicate the position of mutated putative NLS
motifs.
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reveal a classical NLS that ful¢lls all the named require-
ments. However, three amino acid stretches came close
to a NLS and were studied as putative NLS of
PDX-1: K170YISRPRRVE179, R198RMKWKKEED207 and
E205EDKKRSSG213. Whereas mutations R174A+R177A
(Fig. 3B) or K208N+K209Q+R210L (Fig. 3C) did not change
the translocation pattern of GFP-tagged PDX-1, mutation of
amino acids R199A+K203A in the R198RMKWKKEED207
sequence (Fig. 3D) clearly shifted the PDX-1VGFP distribu-
tion pattern from almost exclusively nuclear to that very sim-
ilar of GFP alone, i.e. throughout the cell (Fig. 3E). Because
the PDX-1VGFP fusion protein with a molecular weight of
58 kDa still remains below the cut-o¡ for nuclear import by
di¡usion [22], the destruction of the NLS in a PDX-1VGFP
fusion protein was expected to lead to the obtained distribu-
tion pattern (Fig. 3D), i.e. throughout the cell, rather than to
result in a ‘spared-out-nucleus’ pattern.
The identi¢ed putative NLS consists of RRMKWKK and
forms, according to Boulikas [23], a aaxaxa or axaxaa motif,
where a represents Arg or Lys and x stands for any amino
acid residue except Phe, Trp, Tyr, Glu and Asp. The fact that
the stretch of positively charged amino acids is interrupted by
two hydrophobic amino acid residues (Met and Trp), where
Trp in addition is rather bulky, and is £anked by hydrophobic
residues Trp-Phe makes the by us identi¢ed putative NLS
atypical.
In order to test whether this putative NLS is able to confer
NLS function to a heterologous protein, we tested the PDX-1
sequence WFQNRRMKWKKEEDK as an NLS-tag for the
green £uorescent protein. Indeed, N-terminal fusion of GFP
with the PDX-1 NLS-containing sequence shifted the GFP
distribution pattern from throughout the cell to strongly nu-
clear-localized (Fig. 3E,F). The fact, that the PDX-1194ÿ208
sequence did not lead to an exclusive translocation of GFP
to the nucleus could be explained by (1) an improper local-
ization of the NLS within the NLSVGFP molecule or (2) the
fact that the by us identi¢ed NLS sequence represents only a
part of a complete PDX-1 NLS. The involvement of the ad-
jacent located KKR210 motif in the formation of a putative
bipartite basic NLS can be excluded by the fact that mutation
of this motif per se did not lead to an impaired nuclear trans-
location of PDX-1VGFP (Fig. 3C). To test whether improp-
er localization of the PDX-1194ÿ208 sequence in the PDX-
1VGFP molecule caused its incomplete nuclear translocation,
we extended the PDX-1 sequence to 194^222, thereby spacing
it further from the GFP moiety. As an alternative approach,
we fused the NLS motif-containing PDX-1 sequence 193^208
to the C-terminus of GFP, also spaced by 20 amino acids.
Fig. 2. The role of phosphorylation sites in nuclear translocation of PDX-1. A: Intracellular distribution of GFP-tagged glucocorticoid receptor
12 min following stimulation with 1 WM dexamethasone. B,C: Localization of C-terminally (PDX-1VGFP) and N-terminally (GFPVPDX-1)
tagged PDX-1. D^L: In£uence of indicated mutations on intracellular localization of GFP-tagged PDX-1. Representative images (out of a total
of 20) are shown.
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However, both attempts did not lead to an exclusive nuclear
translocation of the created fusion proteins. Exclusive nuclear
translocation was achieved when extending the PDX-1 se-
quence to 185^209 (Fig. 3G). Inclusion of Lys209 into the
PDX-1184ÿ209 sequence was unlikely to be the reason for
this e¡ect since mutation of this amino acid did not hinder
nuclear translocation of PDX-1VGFP (Fig. 3C). The N-ter-
minal extension from amino acid 193 to 185 caused two ef-
fects: (1) it completed the ‘turn-helix 3’ domain of the PDX-1
homeodomain, i.e. amino acids 185^205, and (2) it introduced
three positively charged amino acids, Arg189, His190 and
Lys192. To test whether the introduction of these three posi-
tively charged amino acids caused the exclusive nuclear trans-
location of GFPVPDX-1185ÿ209, we generated separate muta-
tions, R189A, H190D and K192A, which allowed for the
maintenance of the helical structure of the ‘helix 3’ domain.
Whereas mutations R189A and H190D did not alter the nu-
clear translocation of GFPVPDX-1185ÿ209, mutation K192A
led to a less e⁄cient nuclear translocation (Fig. 3H^J). Inter-
estingly, Lys192 is part of the most highly conserved region of
the homeodomain, KIWFQN [24]. That the integrity of this
motif per se is not a requirement for exclusive nuclear trans-
location was tested by exchanging Ile193 versus Gln, a muta-
tion that abolished DNA-binding [25]. This did not hinder
nuclear translocation of PDX-1VGFP (data not shown).
3.3. Glucose-dependent translocation of GFP-tagged PDX-1
Two recent reports addressed the question of glucose-de-
pendent translocation of PDX-1 in insulin-producing MIN6
cells with di¡erent results [17,18]. Whereas Macfarlane et al.
[17] demonstrated a glucose-dependent cytoplasmic-nuclear
translocation of PDX-1, Ra¢q et al. [18] reported an intra-
nuclear change of PDX-1 distribution but did not observe a
glucose-dependent cytoplasmic-nuclear translocation.
We aimed to address this question by monitoring on-line
the potential glucose-induced cytoplasmic-nuclear transloca-
tion of GFP-tagged PDX-1. That stimulus-induced cytoplas-
mic-nuclear translocation can be studied in MIN6 cells by this
approach has been proven by the dexamethasone-induced
translocation of GFP-tagged glucocorticoid receptor (Fig.
4A^D). To analyze the potential glucose-dependent transloca-
tion of PDX-1, we looked for a condition where PDX-1 is
enriched in the cytoplasm, i.e. where it is not yet translocated
to the nucleus or has left the nucleus. However, neither short-
term (up to 1 h) nor long-term (6^24 h) glucose starvation
(0.5^2 mM glucose) following transfection led to an enhanced
Fig. 3. The role of stretches of positively charged amino acids in nuclear translocation of PDX-1. A: Nuclear localization of PDX-1VGFP.
B^D: In£uence of indicated mutations on the intracellular localization of GFP-tagged PDX-1. E: Intracellular distribution of GFP. F: In£u-
ence of N-terminal fusion of GFP with the putative PDX-1 NLS motif WFQNRRMKWKKEEDK208. G^J: In£uence of C-terminal fusion of
GFP with wild-type and mutated PDX-1 amino acids 185^209. Representative images (out of a total of 20) are shown.
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localization of GFP-tagged PDX-1 in the cytoplasm (Fig. 4E^
H). This was the case for MIN6 cells that were long-term-
cultured at either 11 mM (starved at 2 mM glucose) or 5 mM
glucose (starved at 0.5 mM glucose). This means, that we
could not observe a nuclear to cytoplasm export of PDX-1
at reduced glucose concentrations. That the GFP-tag does not
hinder the export of proteins from the nucleus has previously
been demonstrated for GFP-tagged glucocorticoid receptors
which return to the cytoplasm following removal of dexame-
thasone [19]. This ¢nding was con¢rmed in this study on
MIN6 cells (data not shown). On the other hand, if PDX-1
is actively translocated into the nucleus via the importin-Ran
mechanism, this should be an energy-dependent step, i.e.
GTP-dependent. In addition, endogenous PDX-1 biosynthesis
may be glucose-dependent. The localization of freshly trans-
lated cytoplasmic PDX-1 molecules would have been missed
in our detection system, because we monitored PDX-1VGFP
chimeras by £uorescence, and the formation of the GFPS65T
£uorophore after translation takes 30^60 min [26]. Therefore,
the observed glucose-dependency in [17] may re£ect the com-
bination of the glucose-dependency of PDX-1 biosynthesis
and its energy-dependent nuclear translocation rather than a
glucose-dependent cytoplasmic-nuclear cycling of PDX-1.
3.4. Conclusion
Whereas nuclear import of PDX-1 does not seem to be
dependent on the phosphorylation of a single speci¢c phos-
phorylation site of PDX-1, it is dependent on the presence of
the NLS motif RRMKWKK. This motif is conserved in
mouse, rat and human PDX-1 sequences. The position of
the NLS sequence, i.e. being part of the homeodomain, is in
agreement with a previous observation by Lu et al. [25] that
was obtained by deletional analysis. In fact, for exclusive nu-
clear translocation, the structural integrity of the ‘helix 3’
domain of the PDX-1 homeodomain seems to be a require-
ment and the presence of Lys192 facilitates this process. Our
data do not explain the shift in molecular weight of PDX-1
from 31 kDa prior to translocation to 46 kDa after trans-
location, as reported by Macfarlane et al. [17]. However, the
identi¢cation of a NLS in PDX-1 makes a piggyback mecha-
nism, where the NLS is provided by the piggyback partner,
unlikely. Although biosynthesis and nuclear import of PDX-1
are generally energy-dependent, our data show that PDX-1
does not cycle between the nucleus and cytoplasm in a glu-
cose-dependent manner. Nuclear translocation of PDX-1 is a
requirement for its action. Hence, the region encoding the
‘helix 3’ domain of the PDX-1 homeodomain is a further
candidate region for MODY4.
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